COCRYSTAL PHARMA, INC. Retained Earnings
COCRYSTAL PHARMA, INC. (COCP) had Retained Earnings of -$347.71 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$347.71M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$344.55M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$342.25M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$339.82M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$347.71M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$344.55M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$342.25M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$339.82M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$337.77M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$335.72M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$333.42M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$330.15M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$325.21M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$319.87M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$315.91M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$311.45M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$307.29M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$303.12M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$297.93M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$293.43M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$287.73M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$263.30M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$259.09M 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$255.41M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$251.47M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$247.65M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$244.91M 10-K · filed 2022-03-23 | |
| 2020-09-30 | -$243.41M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | -$240.75M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$237.25M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | -$235.26M 10-K · filed 2021-03-17 | |
| 2019-09-30 | -$187.41M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$185.63M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$184.12M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | -$187.09M 10-K · filed 2020-03-27 | |
| 2018-09-30 | -$142.81M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$140.94M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$139.60M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$138.04M 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$143.24M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | -$140.98M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$139.98M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$137.43M 10-K · filed 2018-03-21 | |
| 2016-09-30 | -$71.68M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$69.80M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$66.57M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$62.56M 10-K · filed 2017-03-31 | |
| 2015-09-30 | -$32.11M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$31.60M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$28.98M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | -$12.43M 10-K · filed 2016-03-15 | |
| 2014-09-30 | -$10.53M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$7.98M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | -$12.34M 10-K · filed 2015-03-31 | -$33.75M 10-K · filed 2014-03-31 |
| 2013-09-30 | -$21.66M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | -$16.35M 10-Q · filed 2013-08-15 | |
| 2013-03-31 | -$15.60M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$14.13M 10-K · filed 2014-03-31 | |
| 2012-09-30 | -$10.62M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$10.52M 10-Q/A · filed 2012-09-28 | -$17.41M 10-Q/A · filed 2012-09-06 |
| 2012-03-31 | -$9.81M 10-Q/A · filed 2012-10-02 | |
| 2011-12-31 | -$6.16M 10-K · filed 2013-04-01 | |
| 2011-09-30 | -$4.37M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | -$2.03M 10-Q/A · filed 2011-09-09 | |
| 2010-12-31 | -$706.17K 10-K · filed 2012-04-16 | -$920.93K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |